Review of clinical practice guidelines for postpartum hemorrhage according to AGREE II

被引:1
|
作者
Zhang, Rongli [1 ]
Cao, Xiao [2 ]
Feng, Haoxue
Liu, Ying [3 ]
Cui, Ping [3 ]
Jiang, Hui [4 ]
机构
[1] Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China
[2] Lanzhou Univ, Evidence Based Nursing Ctr, Sch Nursing, Lanzhou, Peoples R China
[3] Shanghai First Matern & Infant Hosp, Delivery Room, Shanghai 201204, Peoples R China
[4] Shanghai First Matern & Infant Hosp, Nursing Dept, Shanghai 201204, Peoples R China
关键词
PPH; Clinical practice guidelines; AGREE II; Quality; QUALITY; MANAGEMENT; SOCIETY;
D O I
10.1016/j.midw.2023.103659
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Background: Clinical practice guidelines for postpartum hemorrhage (PPH) are available worldwide, but no review has assessed the quality of these guidelines. Poor-quality guidelines for PPH may lead clinicians to follow incorrect approaches. Objectives: High-quality guidelines for PPH are important in guiding the clinical diagnosis and treatment of PPH and decreasing maternal mortality. The aim of this study was to assess the quality of clinical guidelines for PPH.Methods: We collected studies from different countries through a literature search including PubMed (MEDLINE), Web of Science, the Cochrane library, websites of health institutions from multiple countries, and search sites, according to the criterion of clinical guidelines for treatment of PPH published between inception and October 2022. Four independent reviewers assessed the eligible guidelines by using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument. Agreement among reviewers of the guidelines was measured with the intra-class correlation coefficient (ICC). The number of recommendations, strength of recommendations, and level of evidence were determined.Results: Seven sets of PPH guidelines published from 2007 to 2022 were identified. An overall high agreement among reviewers in each domain was observed (ICC 0.74 to 0.95). The median scores and ranges for each AGREE II domain were as follows: (i) scope and purpose (median = 86.51%, range: 61.11%- 94.44%); (ii) stakeholder involvement (median = 73.02%, range: 52.78%-90.28%); (iii) rigor of development (median = 76.49%, range: 66.15%-97.92%); (iv) clarity and presentation (median = 88.49%, range: 68.06%-10 0.0 0%); (v) applicability (median = 73.36%, range: 53.13%-93.75%); and (vi) editorial independence (median = 84.52%, range: 60.42%-95.83%). Three sets of PPH guidelines scored high in all domains and were classified as recommended for clinical practice. The other guidelines were classified as recommended with modifications. Conclusion: The methodological and reporting quality of the guidelines for PPH included in this review was generally good, but the strength of the recommendations and the quality of the evidence varied, thus potentially leading to confusion among clinicians applying the guidelines. An urgent need exists for rigorous studies to close important evidence gaps to support the development of guidelines for PPH. & COPY; 2023 Published by Elsevier Ltd.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] The AGREE Enterprise: a decade of advancing clinical practice guidelines
    Julie Makarski
    Melissa C Brouwers
    Implementation Science, 9
  • [42] Selecting a strategy for prevention of contrast-induced nephropathy in clinical practice: an evaluation of different clinical practice guidelines using the AGREE tool
    Vanommeslaeghe, Floris
    De Mulder, Elien
    Van de Bruaene, Cedric
    Van de Bruaene, Laurens
    Lameire, Norbert
    Van Biesen, Wim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (08) : 1300 - 1306
  • [43] The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines
    Brouwers, Melissa C.
    Kho, Michelle E.
    Browman, George P.
    Burgers, Jako S.
    Cluzeau, Francoise
    Feder, Gene
    Fervers, Beatrice
    Graham, Ian D.
    Grimshaw, Jeremy
    Hanna, Steven E.
    Littlejohns, Peter
    Makarski, Julie
    Zitzelsberger, Louise
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2012, 65 (05) : 526 - 534
  • [44] Quality of Dutch dermatological guidelines according to AGREE II
    Borgonjen, R. J.
    Lubeek, S. F. K.
    Bik, C. M.
    van Everdingen, J. J. E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (04) : E135 - E137
  • [45] Quality of guidelines for hyperthyroidism: systematic quality assessment using the AGREE II tool
    Wang, Yuanshan
    Zhang, Jun
    Cheng, Xiaoliang
    Duan, Xiaoling
    Liang, Ying
    Sun, Dali
    POSTGRADUATE MEDICINE, 2025, 137 (02) : 139 - 147
  • [46] Postpartum Hemorrhage: A Comprehensive Review of Guidelines
    Giouleka, Sonia
    Tsakiridis, Ioannis
    Kalogiannidis, Ioannis
    Mamopoulos, Apostolos
    Tentas, Ioannis
    Athanasiadis, Apostolos
    Dagklis, Themistoklis
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (11) : 665 - 682
  • [47] Nursing Practice Guidelines in China do Need Reform: A Critical Appraisal Using the AGREE II Instrument
    Jin, Yinghui
    Wang, Yunyun
    Zhang, Yao
    Ma, Yue
    Li, Yan
    Lu, Cui
    Wang, Wei
    Li, Ge
    Shang, Hongcai
    WORLDVIEWS ON EVIDENCE-BASED NURSING, 2016, 13 (02) : 124 - 138
  • [48] Systematic review and appraisal of clinical practice guidelines on pelvic organ prolapse using the AGREE II tool
    Tsiapakidou, Sofia
    Nygaard, Christiana Campani
    Falconi, Gabriele
    Pape, Janna
    Betschart, Cornelia
    Doumouchtsis, Stergios K.
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 (06) : 1402 - 1413
  • [49] Appraisal of clinical practice guidelines on community-acquired pneumonia in children with AGREE II instrument
    Zhenwei Xie
    Xiaoling Wang
    Lin Sun
    Jun Liu
    Yan Guo
    Baoping Xu
    Libo Zhao
    Adong Shen
    BMC Pediatrics, 16
  • [50] Appraisal of clinical practice guidelines for salivary gland cancer management utilizing AGREE II instrument
    Chen, Kaiwen
    Lee, Young
    Kuriakose, Jonathan P.
    Khan, Najm S.
    Moreira, Alvaro
    Rajasekaran, Karthik
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (04)